Arnaud Hocquelet
Overview
Explore the profile of Arnaud Hocquelet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavon A, Rubimbura V, Nowacka A, Hocquelet A, Schwitter J, Rotzinger D
Front Cardiovasc Med
. 2023 Jun;
10:1100916.
PMID: 37273871
Hepatic microwave ablation (MWA) is a growing treatment modality in the field of primary and secondary liver cancer. One potential side effect is thermal damage to adjacent structures, including the...
2.
Artru F, Vietti-Violi N, Sempoux C, Vieira Barbosa J, Becce F, Sah N, et al.
JHEP Rep
. 2022 Jul;
4(8):100511.
PMID: 35801087
Background & Aims: We aimed to evaluate long-term outcome of patients with chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein recanalisation (PVR) without transjugular intrahepatic portosystemic shunt...
3.
Vermersch M, Denys A, Artru F, Tsoumakidou G, Villard N, Duran R, et al.
BJR Case Rep
. 2022 Feb;
8(1):20210080.
PMID: 35136636
Objectives: Bleeding risk after percutaneous portal vein access procedures is not negligible. Various agents, coils and plug, have been used to minimize this risk, each with their own advantages and...
4.
Nguyen N, Rode A, Trillaud H, Aube C, Manichon A, Hocquelet A, et al.
Liver Int
. 2021 Dec;
42(4):905-917.
PMID: 34894060
Background & Aims: Long-term outcomes after percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) have been poorly studied. We aim to determine...
5.
Dallaudiere B, Sylvain B, Poussange N, Reboul G, Silvestre A, Meyer P, et al.
Eur J Radiol
. 2021 Sep;
144:109928.
PMID: 34562742
Objectives: The potential contribution of ultrasound (US) to diagnose adductor longus (AL) tendinopathy in athletic pubalgia requires clarification. We investigate US findings from AL tendons of asymptomatic participants to identify...
6.
Nault J, Blanc J, Moga L, Calderaro J, Dao T, Guiu B, et al.
Clin Res Hepatol Gastroenterol
. 2021 Aug;
46(1):101765.
PMID: 34333196
Hepatocellular benign liver tumours are mainly developed on normal liver and include hepatic hemangioma, focal nodular hyperplasia and hepatocellular adenoma from the most frequent to the less frequent. The diagnosis...
7.
Moschouri E, Hocquelet A, Vermersch M, Fraga M, Denys A, Artru F
Clin Res Hepatol Gastroenterol
. 2021 Apr;
45(4):101715.
PMID: 33930593
No abstract available.
8.
Giraud N, Saut O, Aparicio T, Ronchin P, Bazire L, Barbier E, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33430396
Purpose: Chemo-radiotherapy (CRT) is the standard treatment for non-metastatic anal squamous cell carcinomas (ASCC). Despite excellent results for T1-2 stages, relapses still occur in around 35% of locally advanced tumors....
9.
Girardet R, Boughdad S, Digklia A, Beigelman C, Meyer M, Schaefer N, et al.
Cardiovasc Intervent Radiol
. 2020 Aug;
43(11):1712-1715.
PMID: 32761249
Hepatocellular carcinoma (HCC) has the tendency to invade the portal and/or hepatic venous system. The invasion of the right atrium is uncommonly observed and constitutes a treatment challenge. We report...
10.
Vermersch M, Duran R, Violi N, Villard N, Tsoumakidou G, Denys A, et al.
Cardiovasc Intervent Radiol
. 2020 Jul;
43(11):1725-1727.
PMID: 32728797
No abstract available.